Hepatitis B is a major public health problem. Approximately one-third of the world’s population has serological evidence of infection with hepatitis B virus (HBV). 350 million of these are carriers who have chronic HBV infection, and about a million of these carriers die each year from chronic liver disease, including cirrhosis and liver cancer. Fortunately, HBV is a vaccine preventable disease, and the increasing adoption of this vaccine has led to dramatic reductions in the morbidity and mortality caused by this virus. However, as much as 10% of the population fails to mount a protective immune response after vaccination. Twin and other epidemiological studies have demonstrated an unusually high heritability to this trait, which suggests a high likelihood of identifying genetic variation influencing HBV vaccine response. In search of such variation, we performed a two stage Genome Wide Association Scan (GWAS) in participants of a vaccine efficacy trial from Batam, Indonesia. In Stage 1, we used the fixed content Illumina Infinium 550K SNP BeadChip to genotype 2000 vaccinees. Tests of association were performed to identify 7,000 SNPs to carry forward to a second stage of 2,300 vaccinees. Several independent regions attained genome-wide significance, including the HLA-DR and HLA-DP regions. Additional details on the study design and results will be discussed in the presentation.
. 2011 Jan 10;5(Suppl 1):O3.
Genetic determinants of hepatitis B vaccine response
Eileen Png
1,✉, Anbupalam Thalamuthu
1, Rick TH Ong
1, Harm Snippe
2, Herawati Sudoyo
3, David H Muljono
3, Sangkot Marzuki
3, Greet J Boland
2, Mark Seielstad
1,4
Anbupalam Thalamuthu
1Genome Institute of Singapore, Singapore 138672
Find articles by Anbupalam Thalamuthu
Harm Snippe
2Department of Medical Microbiology and Virology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands
Find articles by Harm Snippe
Herawati Sudoyo
3Eijkman Institute for Molecular Biology, Jakarta 10430, Indonesia
Find articles by Herawati Sudoyo
David H Muljono
3Eijkman Institute for Molecular Biology, Jakarta 10430, Indonesia
Find articles by David H Muljono
Sangkot Marzuki
3Eijkman Institute for Molecular Biology, Jakarta 10430, Indonesia
Find articles by Sangkot Marzuki
Greet J Boland
2Department of Medical Microbiology and Virology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands
Find articles by Greet J Boland
Mark Seielstad
1Genome Institute of Singapore, Singapore 138672
4Current Address: Institute for Human Genetics, University of California, San Francisco, CA 94143; and Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118, USA
Find articles by Mark Seielstad
1Genome Institute of Singapore, Singapore 138672
2Department of Medical Microbiology and Virology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands
3Eijkman Institute for Molecular Biology, Jakarta 10430, Indonesia
4Current Address: Institute for Human Genetics, University of California, San Francisco, CA 94143; and Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118, USA
✉
Corresponding author.
Supplement
Institut Pasteur International Network Annual Scientific Meeting
Roberto Bruzzone
Conference
22–23 November 2010
Institut Pasteur International Network Annual Scientific Meeting
Hong Kong
Collection date 2011.
Copyright ©2011 Png et al; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC3019406
